Early life trauma, depression and the glucocorticoid receptor gene-an epigenetic perspective

Psychological Medicine

Volumn 45, Issue 16, 2015, Pages 3393-3410

  Smart, C ^a   Strathdee, G ^a   Watson, S ^a,b   Murgatroyd, C ^c   McAllister Williams, R H ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Depression; early life trauma; epigenetics; NR3C1

Indexed keywords

GLUCOCORTICOID RECEPTOR; NR3C1 PROTEIN, HUMAN;

CHILDHOOD TRAUMA SURVIVOR; DEPRESSION; DISEASE PREDISPOSITION; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PHYSIOLOGY;

ADULT SURVIVORS OF CHILD ADVERSE EVENTS; DEPRESSION; DISEASE SUSCEPTIBILITY; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID;

EID: 84945489785     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715001555     Document Type: Review

References (182)

1. Aberg KA,McClay JL, Nerella S, Clark S, Kumar G, ChenW, Khachane AN, Xie L, Hudson A, Gao G, Harada A, Hultman CM, Sullivan PF, Magnusson PK, van den Oord EJ (2014). Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 71, 255-264.
2. Akbarian S, Huang HS (2009). Epigenetic regulation in human brain-focus on histone lysine methylation. Biological Psychiatry 65, 198-203.
3. Alt SR, Turner JD, Klok MD, Meijer OC, Lakke EA, Derijk RH, Muller CP (2010). Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 35, 544-556.
4. Anacker C, Zunszain PA, Carvalho LA, Pariante CM (2011). The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36, 415-425.
5. Anisman H, Zaharia MD, Meaney MJ, Merali Z (1998). Do early-life events permanently alter behavioral and hormonal responses to stressors? International Journal of Developmental Neuroscience 16, 149-164.
6. Antypa N, Serretti A, Rujescu D (2013). Serotonergic genes and suicide: a systematic review. European Neuropsychopharmacology 23, 1125-1142.
7. Archer T, Oscar-Berman M, Blum K, Gold M (2013). Epigenetic modulation of mood disorders. Journal of Genetic Syndromes and Gene Therapy 4, 1000120.
8. Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G (2007). The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. Journal of Psychiatric Research 41, 290-294.
9. Babenko O, Kovalchuk I, Metz GA (2015). Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neuroscience and Biobehavioral Reviews 48C, 70-91.
10. Bagot RC, Labonte B, Pena CJ, Nestler EJ (2014). Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues in Clinical Neuroscience 16, 281-295.
11. Bakulski KM, Fallin MD (2014). Epigenetic epidemiology: promises for public health research. Environmental and Molecular Mutagenesis 55, 171-183.
12. Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, Nestler EJ (2010). Early life programming and neurodevelopmental disorders. Biological Psychiatry 68, 314-319.
13. Barbosa LP, Quevedo L, da Silva Gdel G, Jansen K, Pinheiro RT, Branco J, Lara D, Oses J, da Silva RA (2014). Childhood trauma and suicide risk in a sample of young individuals aged 14-35 years in southern Brazil. Child Abuse and Neglect 38, 1191-1196.
14. Belvederi Murri M, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, Antonioli M, Ghio L, Menchetti M, Zanetidou S, Innamorati M, Amore M (2014). HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology 41, 46-62.
15. Bifulco A, Brown GW, Adler Z (1991). Early sexual abuse and clinical depression in adult life. British Journal of Psychiatry 159, 115-122.
16. Binder EB (2009). The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34 (Suppl. 1), S186-S195.
17. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305.
18. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Bruckl T, Muller N, Pfister H, Lieb R, Mueller JC, Lohmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, 1319-1325.
19. Bird A (2002). DNA methylation patterns and epigenetic memory. Genes and Development 16, 6-21.
20. Bird A (2007). Perceptions of epigenetics. Nature 447, 396-398.
21. Bockmuhl Y, Murgatroyd CA, Kuczynska A, Adcock IM, Almeida OF, Spengler D (2011). Differential regulation and function of 5?-untranslated GR-exon 1 transcripts. Molecular Endocrinology 25, 1100-1110.
22. Bohacek J, Gapp K, Saab BJ, Mansuy IM (2013). Transgenerational epigenetic effects on brain functions. Biological Psychiatry 73, 313-320.
23. Bohacek J, Mansuy IM (2013). Epigenetic inheritance of disease and disease risk. Neuropsychopharmacology 38, 220-236.
24. Booij L, Wang D, Levesque ML, Tremblay RE, Szyf M (2013). Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Philosophical Transactions of the Royal Society of London, Series B, Biological Sciences 368, 20120251.
25. Bouma EM, Riese H, Nolte IM, Oosterom E, Verhulst FC, Ormel J, Oldehinkel AJ (2011). No associations between single nucleotide polymorphisms in corticoid receptor genes and heart rate and cortisol responses to a standardized social stress test in adolescents: the TRAILS study. Behavior Genetics 41, 253-261.
26. Bowes L, Jaffee SR (2013). Biology, genes, and resilience: toward a multidisciplinary approach. Trauma, Violence and Abuse 14, 195-208.
27. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ (2005). Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proceedings of the National Academy of Sciences of the USA 102, 473-478.
28. Brown GW, Craig TK, Harris TO, Herbert J, Hodgson K, Tansey KE, Uher R (2014). Functional polymorphism in the brain-derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression. Depression and Anxiety 31, 326-334.
29. Caldji C, Diorio J, Meaney MJ (2000). Variations in maternal care in infancy regulate the development of stress reactivity. Biological Psychiatry 48, 1164-1174.
30. Calfa G, Kademian S, Ceschin D, Vega G, Rabinovich GA, Volosin M (2003). Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology 28, 687-701.
31. Callaway E (2014). Epigenomics starts to make its mark. Nature 508, 22.
32. Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF, Anderson GM, Wilkinson CW, Price LH (2007). Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biological Psychiatry 62, 1080-1087.
33. Casey BJ, Craddock N, Cuthbert BN, Hyman SE, Lee FS, Ressler KJ (2013). DSM-5 and RDoC: progress in psychiatry research? Nature Reviews, Neuroscience 14, 810-814.
34. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
35. Castillo-Fernandez JE, Spector TD, Bell JT (2014). Epigenetics of discordant monozygotic twins: implications for disease. Genome Medicine 6, 60.
36. Chang SC, Glymour MM, Walter S, Liang L, Koenen KC, Tchetgen EJ, Cornelis MC, Kawachi I, Rimm E, Kubzansky LD (2014). Genome-wide polygenic scoring for a 14-year long-term average depression phenotype. Brain and Behavior 4, 298-311.
37. Cohen-Woods S, Craig IW, McGuffin P (2013). The current state of play on the molecular genetics of depression. Psychological Medicine 43, 673-687.
38. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V, Sahakian BJ, Saxena S, Singer PA, Stein DJ, Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health (2011). Grand challenges in global mental health. Nature 475, 27-30.
39. Conradt E, Lester BM, Appleton AA, Armstrong DA, Marsit CJ (2013). The roles of DNA methylation of NR3C1 and 11?-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior. Epigenetics 8, 1321-1329.
40. Cowen PJ (2010). Not fade away: the HPA axis and depression. Psychological Medicine 40, 1-4.
41. Crean AJ, Kopps AM, Bonduriansky R (2014). Revisiting telegony: offspring inherit an acquired characteristic of their mother's previous mate. Ecology Letters 17, 1545-1552.
42. Danchin E, Charmantier A, Champagne FA, Mesoudi A, Pujol B, Blanchet S (2011). Beyond DNA: integrating inclusive inheritance into an extended theory of evolution. Nature Reviews, Genetics 12, 475-486.
43. Daniels WM, Fairbairn LR, van Tilburg G, McEvoy CR, Zigmond MJ, Russell VA, Stein DJ (2009). Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metabolic Brain Disease 24, 615-627.
44. Daskalakis NP, Bagot RC, Parker KJ, Vinkers CH, de Kloet ER (2013). The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology 38, 1858-1873.
45. Daskalakis NP, Yehuda R (2014). Site-specific methylation changes in the glucocorticoid receptor exon 1F promoter in relation to life adversity: systematic review of contributing factors. Frontiers in Neuroscience 8, 369.
46. Day JJ, Sweatt JD (2011). Epigenetic mechanisms in cognition. Neuron 70, 813-829.
47. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, Kalidindi S, Picchioni M, Kravariti E, Toulopoulou T, Murray RM, Mill J (2011). Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Human Molecular Genetics 20, 4786-4796.
48. Dempster EL, Wong CC, Lester KJ, Burrage J, Gregory AM, Mill J, Eley TC (2014). Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression. Biological Psychiatry 76, 977-983.
49. Denenberg VH, Rosenberg KM (1967). Nongenetic transmission of information. Nature 216, 549-550.
50. Dyer O (2014). Journal retracts article that said childhood trauma could lead to genetic changes. BMJ 349, g5543.
51. Eaves L, Silberg J, Erkanli A (2003). Resolving multiple epigenetic pathways to adolescent depression. Journal of Child Psychology and Psychiatry, and Allied Disciplines 44, 1006-1014.
52. Edelman S, Shalev I, Uzefovsky F, Israel S, Knafo A, Kremer I, Mankuta D, Kaitz M, Ebstein RP (2012). Epigenetic and genetic factors predict women's salivary cortisol following a threat to the social self. PLOS ONE 7, e48597.
53. Ehlert U (2013). Enduring psychobiological effects of childhood adversity. Psychoneuroendocrinology 38, 1850-1857.
54. El-Sayed AM, Haloossim MR, Galea S, Koenen KC (2012). Epigenetic modifications associated with suicide and common mood and anxiety disorders: a systematic review of the literature. Biology of Mood and Anxiety Disorders 2, 10.
55. Elzinga BM, Roelofs K, Tollenaar MS, Bakvis P, van Pelt J, Spinhoven P (2008). Diminished cortisol responses to psychosocial stress associated with lifetime adverse events a study among healthy young subjects. Psychoneuroendocrinology 33, 227-237.
56. Engineer N, Darwin L, Nishigandh D, Ngianga-Bakwin K, Smith SC, Grammatopoulos DK (2013). Association of glucocorticoid and type 1 corticotropin-releasing hormone receptors gene variants and risk for depression during pregnancy and post-partum. Journal of Psychiatric Research 47, 1166-1173.
57. Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH, Joyce E, Rowe J, Wellsted D, Nutt DJ, Sahakian BJ (2013). The size, burden and cost of disorders of the brain in the UK. Journal of Psychopharmacology 27, 761-770.
58. Finkelhor D, Shattuck A, Turner HA, Hamby SL (2014). The lifetime prevalence of child sexual abuse and sexual assault assessed in late adolescence. Journal of Adolescent Health 55, 329-333.
59. Fish EW, Shahrokh D, Bagot R, Caldji C, Bredy T, Szyf M, Meaney MJ (2004). Epigenetic programming of stress responses through variations in maternal care. Annals of the New York Academy of Sciences 1036, 167-180.
60. Flint J, Kendler KS (2014). The genetics of major depression. Neuron 81, 484-503.
61. Francis D, Diorio J, Liu D, Meaney MJ (1999). Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286, 1155-1158.
62. Francke U, Foellmer BE (1989). The glucocorticoid receptor gene is in 5q31-q32 [corrected]. Genomics 4, 610-612.
63. Franz CE, Lyons MJ, O'Brien R, Panizzon MS, Kim K, Bhat R, Grant MD, Toomey R, Eisen S, Xian H, Kremen WS (2011). A 35-year longitudinal assessment of cognition and midlife depression symptoms: the Vietnam Era Twin Study of Aging. American Journal of Geriatric Psychiatry 19, 559-570.
64. Galecka E, Szemraj J, Bienkiewicz M, Majsterek I, Przybylowska-Sygut K, Galecki P, Lewinski A (2013). Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland. Molecular Biology Reports 40, 1693-1699.
65. Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN (2007). Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophrenia Research 90, 258-265.
66. Gibbons JL (1964). Cortisol secretion rate in depressive illness. Archives of General Psychiatry 10, 572-575.
67. Glossop JR, Nixon NB, Emes RD, Haworth KE, Packham JC, Dawes PT, Fryer AA, Mattey DL, Farrell WE (2013). Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T-and B-lymphocytes from healthy individuals. Epigenetics 8, 1188-1197.
68. Gusev A, Bhatia G, Zaitlen N, Vilhjalmsson BJ, Diogo D, Stahl EA, Gregersen PK, Worthington J, Klareskog L, Raychaudhuri S, Plenge RM, Pasaniuc B, Price AL (2013). Quantifying missing heritability at known GWAS loci. PLoS Genetics 9, e1003993.
69. Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S (2014). Use of epigenetic drugs in disease: an overview. Genetics and Epigenetics 6, 9-19.
70. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biological Psychiatry 49, 1023-1039.
71. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2008). The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33, 693-710.
72. Heim C, Shugart M, Craighead WE, Nemeroff CB (2010). Neurobiological and psychiatric consequences of child abuse and neglect. Developmental Psychobiology 52, 671-690.
73. Hepgul N, Cattaneo A, Zunszain PA, Pariante CM (2013). Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Medicine 11, 28.
74. Herbert J (2013). Cortisol and depression: three questions for psychiatry. Psychological Medicine 43, 449-469.
75. Holliday R, Pugh JE (1975). DNA modification mechanisms and gene activity during development. Science 187, 226-232.
76. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
77. Hompes T, Izzi B, Gellens E, Morreels M, Fieuws S, Pexsters A, Schops G, Dom M, Van Bree R, Freson K, Verhaeghe J, Spitz B, Demyttenaere K, Glover V, Van den Bergh B, Allegaert K, Claes S (2013). Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. Journal of Psychiatric Research 47, 880-891.
78. Hornung OP, Heim CM (2014). Gene-environment interactions and intermediate phenotypes: early trauma and depression. Frontiers in Endocrinology (Lausanne) 5, 14.
79. Hotchkiss RD (1948). The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. Journal of Biological Chemistry 175, 315-332.
80. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C,Wang P (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 167, 748-751.
81. Ishida K, Klevens J, Rivera-Garcia B, Mirabal B (2013). Child maltreatment in Puerto Rico: findings from the 2010 National Child Abuse and Neglect Data System. Puerto Rico Health Sciences Journal 32, 124-131.
82. IsingM, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Kunzel HE, Pfennig A, Uhr M, Holsboer F (2007). Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker? Biological Psychiatry 62, 47-54.
83. Kanherkar RR, Bhatia-Dey N, Csoka AB (2014). Epigenetics across the human lifespan. Frontiers in Cell and Developmental Biology 2, 49.
84. Karanth S, Linthorst AC, Stalla GK, Barden N, Holsboer F, Reul JM (1997). Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 138, 3476-3485.
85. Kendler KS, Bulik CM, Silberg J, Hettema JM, Myers J, Prescott CA (2000). Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. Archives of General Psychiatry 57, 953-959.
86. Kendler KS, Gatz M, Gardner CO, Pedersen NL (2006). A Swedish national twin study of lifetime major depression. American Journal of Psychiatry 163, 109-114.
87. Kessing LV,Willer IS, Knorr U (2011). Volume of the adrenal and pituitary glands in depression. Psychoneuroendocrinology 36, 19-27.
88. Klengel T, Pape J, Binder EB, Mehta D (2014). The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology 80, 115-132.
89. Koper JW, van Rossum EF, van den Akker EL (2014). Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids 92, 62-73.
90. Labonte B, Yerko V, Gross J, Mechawar N, Meaney MJ, Szyf M, Turecki G (2012). Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biological Psychiatry 72, 41-48.
91. Lahti J, Raikkonen K, Bruce S, Heinonen K, Pesonen AK, Rautanen A, Wahlbeck K, Kere J, Kajantie E, Eriksson JG (2011). Glucocorticoid receptor gene haplotype predicts increased risk of hospital admission for depressive disorders in the Helsinki birth cohort study. Journal of Psychiatric Research 45, 1160-1164.
92. Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR, Sullivan PF (2014). Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it? Biological Psychiatry 76, 510-512.
93. Lewis CM,Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, RiveraM, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, Aitchison KJ, Shi J, Quinn JP, Mackenzie A, Vollenweider P, Waeber G, Heath S, Lathrop M, Muglia P, Barnes MR, Whittaker JC, Tozzi F, Holsboer F, Preisig M, Farmer AE, Breen G, Craig IW, McGuffin P (2010). Genome-wide association study of major recurrent depression in the U.K. population. American Journal of Psychiatry 167, 949-957.
94. Lewis G, Collishaw S, Harold G, Rice F, Thapar A (2012). Maternal depression and child and adolescent depression symptoms: an exploratory test for moderation by CRHR1, FKBP5 andNR3C1 gene variants. BehaviorGenetics 42, 121-132.
95. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney MJ (1997). Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277, 1659-1662.
96. Maher B (2008). Personal genomes: the case of the missing heritability. Nature 456, 18-21.
97. Maniglio R (2009). The impact of child sexual abuse on health: a systematic review of reviews. Clinical Psychology Review 29, 647-657.
98. Massart R, Mongeau R, Lanfumey L (2012). Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philosophical Transactions of the Royal Society of London, Series B, Biological Sciences 367, 2485-2494.
99. Mathers JC, Strathdee G, Relton CL (2010). Induction of epigenetic alterations by dietary and other environmental factors. Advances in Genetics 71, 3-39.
100. May-Chahal C, Cawson P (2005). Measuring child maltreatment in the United Kingdom: a study of the prevalence of child abuse and neglect. Child Abuse and Neglect 29, 969-984.
101. McAllister-Williams RH, Ferrier IN, Young AH (1998). Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychological Medicine 28, 573-584.
102. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience 12, 342-348.
103. McGuffin P, Cohen S, Knight J (2007). Homing in on depression genes. American Journal of Psychiatry 164, 195-197.
104. Meaney MJ (2001). Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annual Review of Neuroscience 24, 1161-1192.
105. Meaney MJ, Diorio J, Francis D, Widdowson J, LaPlante P, Caldji C, Sharma S, Seckl JR, Plotsky PM (1996). Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Developmental Neuroscience 18, 49-72.
106. Meaney MJ, Szyf M (2005). Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues in Clinical Neuroscience 7, 103-123.
107. Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W Jr, Myers RM, Schatzberg A, Akil H, Watson SJ (2013). Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. Journal of Psychiatric Research 47, 307-314.
108. Melas PA, Wei Y, Wong CC, Sjoholm LK, Aberg E, Mill J, Schalling M, Forsell Y, Lavebratt C (2013). Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. International Journal of Neuropsychopharmacology 16, 1513-1528.
109. Moser D, Molitor A, Kumsta R, Tatschner T, Riederer P, Meyer J (2007). The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus. World Journal of Biological Psychiatry 8, 262-268.
110. Mulligan CJ, D'Errico NC, Stees J, Hughes DA (2012). Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight. Epigenetics 7, 853-857.
111. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fischer D, Holsboer F, Wotjak CT, Almeida OF, Spengler D (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nature Neuroscience 12, 1559-1566.
112. Murgatroyd C, Quinn JP, Sharp HM, Pickles A, Hill J (2015). Effects of prenatal and postnatal depression, and maternal stroking, at the glucocorticoid receptor gene. Translational Psychiatry 5, e560.
113. Murgatroyd C, Spengler D (2011). Epigenetics of early child development. Frontiers in Psychiatry 2, 16.
114. Murgatroyd CA, Nephew BC (2013). Effects of early life social stress on maternal behavior and neuroendocrinology. Psychoneuroendocrinology 38, 219-228.
115. Murgatroyd CA, Taliefar M, Bradburn S, Carini LM, Babb JA, Nephew BC (2015). Social stress during lactation, depressed maternal care, and neuropeptidergic gene expression. Behavioural Pharmacology. Published online 8 June 2015. doi:10.1097/FBP.0000000000000147.
116. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA III, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R,Weisskopf MG,Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223.
117. Na KS, Chang HS, Won E, Han KM, Choi S, Tae WS, Yoon HK, Kim YK, Joe SH, Jung IK, Lee MS, Ham BJ (2014). Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder. PLOS ONE 9, e85425.
118. Nair A, Howard R (2013). ENCODE and a new landscape for psychiatric genetics. British Journal of Psychiatry 203, 84-85.
119. Nicolson NA (2004). Childhood parental loss and cortisol levels in adult men. Psychoneuroendocrinology 29, 1012-1018.
120. Nivard MG, Dolan CV, Kendler KS, Kan KJ, Willemsen G, van Beijsterveldt CE, Lindauer RJ, van Beek JH, Geels LM, Bartels M, Middeldorp CM, Boomsma DI (2015). Stability in symptoms of anxiety and depression as a function of genotype and environment: a longitudinal twin study from ages 3 to 63 years. Psychological Medicine 45, 1039-1049.
121. Oberlander TF,Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97-106.
122. O'Toole SM, Sekula LK, Rubin RT (1997). Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biological Psychiatry 42, 85-89.
123. Ou JN, Torrisani J, Unterberger A, Provencąl N, Shikimi K, Karimi M, Ekstrom TJ, Szyf M (2007). Histone deacetylase inhibitor trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochemical Pharmacology 73, 1297-1307.
124. Pariante CM (2006). The glucocorticoid receptor: part of the solution or part of the problem? Journal of Psychopharmacology 20, 79-84.
125. Pariante CM (2009). Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Annals of the New York Academy of Sciences 1179, 144-152.
126. Pariante CM, Lightman SL (2008). The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences 31, 464-468.
127. Pariante CM, Miller AH (2001). Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 49, 391-404.
128. Pepin MC, Pothier F, Barden N (1992). Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Molecular Pharmacology 42, 991-995.
129. Perroud N, Paoloni-Giacobino A, Prada P, Olie E, Salzmann A, Nicastro R, Guillaume S, Mouthon D, Stouder C, Dieben K, Huguelet P, Courtet P, Malafosse A (2011). Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Translational Psychiatry 1, e59.
130. Plank JL, Dean A (2014). Enhancer function: mechanistic and genome-wide insights come together. Molecular Cell 55, 5-14.
131. Plessy C, Desbois L, Fujii T, Carninci P (2013). Population transcriptomics with single-cell resolution: a new field made possible by microfluidics: a technology for high throughput transcript counting and data-driven definition of cell types. BioEssays 35, 131-140.
132. Power RA, Keller MC, Ripke S, Abdellaoui A, Wray NR, Sullivan PF, Group MPW, Breen G (2014). A recessive genetic model and runs of homozygosity in major depressive disorder. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics 165B, 157-166.
133. Provencąl N, Suderman MJ, Guillemin C, Massart R, Ruggiero A, Wang D, Bennett AJ, Pierre PJ, Friedman DP, Côté SM, Hallett M, Tremblay RE, Suomi SJ, Szyf M (2012). The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. Journal of Neuroscience 32, 15626-15642.
134. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60, 436-444.
135. Radford L, Corral S, Bradley C, Fisher HL (2013). The prevalence and impact of child maltreatment and other types of victimization in the UK: findings from a population survey of caregivers, children and young people and young adults. Child Abuse and Neglect 37, 801-813.
136. Radtke KM, Ruf M, Gunter HM, Dohrmann K, Schauer M, Meyer A, Elbert T (2011). Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Translational Psychiatry 1, e21.
137. Razin A, Riggs AD (1980). DNA methylation and gene function. Science 210, 604-610.
138. ReikW(2007). Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432.
139. Reul JM (2014). Making memories of stressful events: a journey along epigenetic, gene transcription, and signaling pathways. Frontiers in Psychiatry 5, 5.
140. Riggs AD (1975). X inactivation, differentiation, and DNA methylation. Cytogenetics and Cell Genetics 14, 9-25.
141. Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, Martin NG, McGuffin P, Muglia P, Noethen MM, Penninx BP, Pergadia ML, Potash JB, Rietschel M, Lin D, Muller-Myhsok B, Shi J, Steinberg S, Grabe HJ, Lichtenstein P, Magnusson P, Perlis RH, Preisig M, Smoller JW, Stefansson K, Uher R, Kutalik Z, Tansey KE, Teumer A, Viktorin A, Barnes MR, Bettecken T, Binder EB, Breuer R, Castro VM, Churchill SE, Coryell WH, Craddock N, Craig IW, Czamara D, De Geus EJ, Degenhardt F, Farmer AE, Fava M, Frank J, Gainer VS, Gallagher PJ, Gordon SD, Goryachev S, Gross M, Guipponi M, Henders AK, Herms S, Hickie IB, Hoefels S, Hoogendijk W, Hottenga JJ, Iosifescu DV, Ising M, Jones I, Jones L, Jung-Ying T, Knowles JA, Kohane IS, Kohli MA, Korszun A, Landen M, Lawson WB, Lewis G, Macintyre D, Maier W, Mattheisen M, McGrath PJ, McIntosh A, McLean A, Middeldorp CM, Middleton L, Montgomery GM, Murphy SN, Nauck M, Nolen WA, Nyholt DR, O'Donovan M, Oskarsson H, Pedersen N, Scheftner WA, Schulz A, Schulze TG, Shyn SI, Sigurdsson E, Slager SL, Smit JH, Stefansson H, Steffens M, Thorgeirsson T, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Volzke H, Weilburg JB, Willemsen G, Zitman FG, Neale B, Daly M, Levinson DF, Sullivan PF, Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (2013). A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry 18, 497-511.
142. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE (2012). The predictive capacity of personal genome sequencing. Science Translational Medicine 4, 133-58.
143. Robinson MD, Kahraman A, Law CW, Lindsay H, Nowicka M, Weber LM, Zhou X (2014). Statistical methods for detecting differentially methylated loci and regions. Frontiers in Genetics 5, 324.
144. Rollins B, Martin MV, Morgan L, Vawter MP (2010). Analysis of whole genome biomarker expression in blood and brain. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics 153B, 919-936.
145. Rutter M (1985). Resilience in the face of adversity. Protective factors and resistance to psychiatric disorder. British Journal of Psychiatry 147, 598-611.
146. Sandhu R, Roll JD, Rivenbark AG, Coleman WB (2015). Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapy. American Journal of Pathology 185, 282-292.
147. Schmidt HD, Shelton RC, Duman RS (2011). Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 36, 2375-2394.
148. Schneider M, Engel A, Fasching PA, Haberle L, Binder EB, Voigt F, Grimm J, Faschingbauer F, Eichler A, Dammer U, Rebhan D, Amann M, Raabe E, Goecke TW, Quast C, Beckmann MW, Kornhuber J, Seifert A, Burghaus S (2014). Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy. Biomed Research International 2014, 469278.
149. Sharp H, Pickles A,MeaneyM,Marshall K, Tibu F, Hill J (2012). Frequency of infant stroking reported bymothers moderates the effect of prenatal depression on infant behavioural andphysiologicaloutcomes.PLOSONE7, e45446.
150. Simar D, Versteyhe S, Donkin I, Liu J, Hesson L, Nylander V, Fossum A, Barres R (2014). DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human. Metabolism 63, 1188-1197.
151. Smith ZD, Meissner A (2013). DNA methylation: roles in mammaliandevelopment.Nature Reviews,Genetics 14, 204-220.
152. Spijker AT, van Rossum EF (2012). Glucocorticoid sensitivity in mood disorders. Neuroendocrinology 95, 179-186.
153. Suderman M, McGowan PO, Sasaki A, Huang TC, Hallett MT, Meaney MJ, Turecki G, Szyf M (2012). Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus. Proceedings of the National Academy of Sciences of the USA 109 (Suppl. 2), 17266-17272.
154. Sulistyoningrum DC, Singh R, Devlin AM (2012). Epigenetic regulation of glucocorticoid receptor expression in aorta from mice with hyperhomocysteinemia. Epigenetics 7, 514-521.
155. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 157, 1552-1562.
156. Sun H, Kennedy PJ, Nestler EJ (2013). Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 38, 124-137.
157. Sweatt JD (2009). Experience-dependent epigenetic modifications in the central nervous system. Biological Psychiatry 65, 191-197.
158. Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Narozna B, Rajewska-Rager A,Wilkosc M, Zaremba D, Maciukiewicz M, Twarowska-Hauser J (2014). FKBP5 polymorphism is associated with major depression but not with bipolar disorder. Journal of Affective Disorders 164, 33-37.
159. Turecki G, Meaney MJ (2014). Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biological Psychiatry. Published online 13 December 2014. doi:10.1016/j. biopsych.2014.11.022.
160. Turner JD, Alt SR, Cao L, Vernocchi S, Trifonova S, Battello N, Muller CP (2010). Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochemical Pharmacology 80, 1860-1868.
161. Turner JD, Muller CP (2005). Structure of the glucocorticoid receptor (NR3C1) gene 5? untranslated region: identification, and tissue distribution of multiplenewhumanexon 1. Journal of Molecular Endocrinology 35, 283-292.
162. Turner JD, Schote AB, Macedo JA, Pelascini LP, Muller CP (2006). Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochemical Pharmacology 72, 1529-1537.
163. Turner JD, Vernocchi S, Schmitz S, Muller CP (2014). Role of the 5?-untranslated regions in post-transcriptional regulation of the human glucocorticoid receptor. Biochimica et Biophysica Acta 1839, 1051-1061.
164. Tylee DS, Kawaguchi DM, Glatt SJ (2013). On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes". American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics 162B, 595-603.
165. Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL (2012). Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLOS ONE 7, e30148.
166. Tyrka AR, Wier L, Price LH, Ross N, Anderson GM, Wilkinson CW, Carpenter LL (2008). Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biological Psychiatry 63, 1147-1154.
167. Uchida S, Nishida A, Hara K, Kamemoto T, SuetsugiM, FujimotoM,WatanukiT,WakabayashiY, Otsuki K,McEwen BS,Watanabe Y (2008). Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. European Journal of Neuroscience 27, 2250-2261.
168. Uher R (2014). Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search. Social Psychiatry and Psychiatric Epidemiology 49, 3-14.
169. Wang Q, Verweij EW, Krugers HJ, Joels M, Swaab DF, Lucassen PJ (2014). Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients. Brain Structure and Function 219, 1615-1626.
170. Watson S, Owen BM, Gallagher P, Hearn AJ, Young AH, Ferrier IN (2007). Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: mediation of the vulnerability to mood disorders. Neuropsychiatric Disease and Treatment 3, 647-653.
171. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, MeaneyMJ (2004). Epigenetic programming by maternal behavior. Nature Neuroscience 7, 847-854.
172. Weaver IC,D'AlessioAC, BrownSE, Hellstrom IC, Dymov S, Sharma S, Szyf M, MeaneyMJ (2007). The transcription factor nerve growth factor-inducible protein A mediates epigenetic programming: altering epigenetic marks by immediate-early genes. Journal of Neuroscience 27, 1756-1768.
173. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS (2002). Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 7, 985-994, 924.
174. Widom CS, DuMont K, Czaja SJ (2007). A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Archives of General Psychiatry 64, 49-56.
175. Wildeman C, Emanuel N, Leventhal JM, Putnam-Hornstein E, Waldfogel J, Lee H (2014). The prevalence of confirmed maltreatment among US children, 2004 to 2011. JAMA Pediatrics 168, 706-713.
176. Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC, Plomin R, Mill J (2014). Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Molecular Psychiatry 19, 495-503.
177. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, Chu AY, Estrada K, Luan J, Kutalik Z, Amin N, Buchkovich ML, Croteau-Chonka DC, Day FR, Duan Y, Fall T, Fehrmann R, Ferreira T, Jackson AU, Karjalainen J, Lo KS, Locke AE, Magi R, Mihailov E, Porcu E, Randall JC, Scherag A, Vinkhuyzen AA, Westra HJ, Winkler TW, Workalemahu T, Zhao JH, Absher D, Albrecht E, Anderson D, Baron J, Beekman M, Demirkan A, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Fraser RM, Goel A, Gong J, Justice AE, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Lui JC, Mangino M, Mateo Leach I, Medina-Gomez C, Nalls MA, Nyholt DR, Palmer CD, Pasko D, Pechlivanis S, Prokopenko I, Ried JS, Ripke S, Shungin D, Stancakova A, Strawbridge RJ, Sung YJ, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Afzal U, Arnlov J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Bluher M, Bolton JL, Bottcher Y, Boyd HA, Bruinenberg M, Buckley BM, Buyske S, Caspersen IH, Chines PS, Clarke R, Claudi-Boehm S, Cooper M, Daw EW, De Jong PA, Deelen J, et al. (2014). Defining the role of common variation in the genomic and biological architecture of adult human height. Nature Genetics 46, 1173-1186.
178. World Health Organization (2008). Global Burden of Disease Report (http://www.who.int/healthinfo/global-burden-disease/estimates-country/en/index.html). Accessed 15 July 2015.
179. Yau JL, Hibberd C, Noble J, Seckl JR (2002). The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Brain Research, Molecular Brain Research 106, 117-123.
180. Yehuda R, Boisoneau D, Mason JW, Giller EL (1993). Glucocorticoid receptornumberandcortisol excretion inmood, anxiety, and psychotic disorders. Biological Psychiatry 34, 18-25.
181. Young AH (2004). Cortisol in mood disorders. Stress 7, 205-208.
182. Zannas AS, Provencąl N, Binder EB (2015). Epigenetics of posttraumatic stress disorder: current evidence, challenges, and future directions. Biological Psychiatry 78, 327-335.